{{Rsnum
|rsid=844648
|Gene=LOC100506023
|Chromosome=1
|position=173254724
|Orientation=plus
|GMAF=0.4339
|Gene_s=IGHVII-15-1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.8 | 51.3 | 31.9
| HCB | 14.7 | 56.6 | 28.7
| JPT | 10.1 | 38.5 | 51.4
| YRI | 31.7 | 46.9 | 21.4
| ASW | 33.3 | 49.1 | 17.5
| CHB | 14.7 | 56.6 | 28.7
| CHD | 27.1 | 47.7 | 25.2
| GIH | 16.8 | 49.5 | 33.7
| LWK | 18.3 | 47.7 | 33.9
| MEX | 28.1 | 49.1 | 22.8
| MKK | 8.4 | 51.0 | 40.6
| TSI | 14.0 | 35.0 | 51.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19357697
|Title=Association of BANK1 and TNFSF4 with systemic lupus erythematosus in Hong Kong Chinese.
|OA=1
}}

{{PMID Auto
|PMID=19778912
|Title=Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis
|OA=1
}}

{{PMID Auto
|PMID=22422496
|Title=Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis
|OA=1
}}

{{PMID|21187296}} A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.

{{PMID Auto
|PMID=22850862
|Title=Association of TNFSF4 polymorphisms with systemic lupus erythematosus: a meta-analysis.
}}

{{PMID Auto
|PMID=22870213
|Title=Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}